Intellia Therapeutics, Inc. (NTLA) Social Stream



Intellia Therapeutics, Inc. (NTLA): $62.04

1.12 (+1.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NTLA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 387

in industry

INTELLIA THERAPEUTICS INC (NTLA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering INTELLIA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-07 15 $193 $85 $157.133 $55.29 184.2%
2022-01-28 16 $193 $85 $156.5 $55.29 183.05%
2022-02-03 17 $193 $85 $156.5 $55.29 183.05%
2022-02-04 17 $193 $85 $151.437 $55.29 173.9%
2022-02-07 18 $193 $85 $151.75 $55.29 174.46%
2022-02-25 19 $193 $85 $151.75 $55.29 174.46%
2022-02-28 17 $193 $85 $151.75 $55.29 174.46%
2022-03-01 17 $193 $85 $152.375 $55.29 175.59%
2022-03-03 17 $193 $85 $152.062 $55.29 175.03%
2022-03-07 17 $193 $85 $148.47 $55.29 168.53%
2022-04-25 17 $193 $85 $146.375 $55.29 164.74%
2022-05-05 16 $193 $85 $148.8 $55.29 169.13%
2022-05-06 16 $193 $55 $140.2 $55.29 153.57%
2022-05-09 16 $193 $55 $138.2 $55.29 149.95%
2022-05-24 17 $193 $55 $137.375 $55.29 148.46%
2022-06-16 19 $193 $55 $133.411 $55.29 141.29%
2022-06-17 19 $193 $54 $129 $55.29 133.32%
2022-07-17 18 $193 $54 $131.437 $55.29 137.72%
2022-08-03 18 $193 $54 $132.312 $55.29 139.31%
2022-08-05 18 $193 $54 $132.625 $55.29 139.87%
2022-08-15 18 $192 $54 $130.125 $55.29 135.35%
2022-09-01 19 $192 $50 $125.411 $55.29 126.82%
2022-09-16 19 $192 $50 $124.588 $55.29 125.34%
2022-09-19 19 $192 $50 $125.823 $55.29 127.57%
2022-09-23 20 $192 $50 $125.111 $55.29 126.28%

The Trend in the Analyst Price Target


NTLA's average price target has moved up $52.82 over the prior 20 months.

Over the past 46 weeks, NTLA's average upside potential has been 118.26%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-28 16 193 85 156.500 86.02 81.93%
2022-02-03 17 193 85 156.500 94.53 65.56%
2022-05-09 16 193 55 138.200 41.45 233.41%
2022-07-17 18 193 54 131.437 63.28 107.71%
2022-09-01 19 192 50 125.411 59.97 109.12%

NTLA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.45 16 1 2 1 1 20

The Trend in the Broker Recommendations


Over the past 48 weeks, NTLA's average broker recommendation rating improved by 0.47.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, INTELLIA THERAPEUTICS INC's number of analysts covering the stock is greater than 2937% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INTELLIA THERAPEUTICS INC's average analyst price target is greater than 2898.87% of them.
  • NTLA has a higher upside potential (average analyst target price relative to current price) than 2805.57% of stocks in the large market cap category.
  • INTELLIA THERAPEUTICS INC's variance in analysts' estimates is lower than -2630.2% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INTELLIA THERAPEUTICS INC are IDXX, ZTS, and ZLAB.

What is the outlook for NTLA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4856 seconds.